Sat.Apr 01, 2023

article thumbnail

Revealed: maker of Wegovy ‘skinny jab’ is funding NHS weight-loss services

The Guardian - Pharmaceutical Industry

Critics fear conflict of interest as Novo Nordisk helps medics ‘reduce unnecessary barriers’ to treatment for obesity The pharmaceutical company that makes Wegovy slimming jabs is funding the expansion of weight-loss services across England as it seeks to boost sales of its obesity drugs, the Observer can reveal. Novo Nordisk is paying the salaries of staff on NHS obesity teams and financing the launch and redesign of services, including giving £206,000 to a health partnership to transform its t

article thumbnail

Reducing Vulnerabilities in Upstream and Downstream Supply Chains

BioPharm

Makers of specialty biologics, gene therapies, and other personalized medicines are working to identify and reduce potential supply chain risks both upstream and downstream.

98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How Pharma-mkting.com Connects HCP’s to the Pharmaceutical and Medical Device Community

Pharma Marketing Network

Pharma-Mkting.com is a leading resource for professionals in the pharmaceutical and medical device industries. With a focus on marketing and digital health, Pharma-Mkting.com provides a wealth of information, resources, and insights to help these industries succeed in an increasingly competitive market. One of the key areas of expertise for Pharma-Mkting.com is pharmaceutical marketing.

article thumbnail

A Message From Alex April 2023

Oswald's

I’m in no way opposed to screen time for kids. Between the educational apps, my kids play with on the iPad to the tradition I’ve carried on from my childhood of Friday pizza & movie nights—screen time can be valuable for education, family bonding, and of course, fun! That being said, our gift & toy… The post A Message From Alex April 2023 appeared first on Oswald's Pharmacy.

52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Kudos and Hurdles in Tackling Rare Diseases

BioPharm

FDA has spurred investment to create and develop 600 therapies.

FDA 75
article thumbnail

April 2023 Promotions

Oswald's

The post April 2023 Promotions appeared first on Oswald's Pharmacy.

52

More Trending

article thumbnail

Purification of Protein by HIC: Mechanistic Modeling for Improved Understanding and Process Optimization

BioPharm

In this article, a simple chromatographic model is proposed that is capable of predicting the impact of pH and ionic strength on HIC chromatograms.

52
article thumbnail

Who’s Got Game?

BioPharm

Direct-to-consumer drug advertising has developed as a cottage industry which has been used to increase prescriptions immensely.

52
article thumbnail

Exploring the Impact of Fixed-Bed Bioreactors in Upstream Processing

BioPharm

The innovation of going from stainless-steel bioreactors to fixed-bed bioreactors shows an evolution in upstream optimization.

40
article thumbnail

Ramping Up Development of Nucleic Acid Therapies

BioPharm

The COVID-19 vaccines opened the door to powerful market potential for other nucleic acid-based therapies.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

SMB Technology Supports Shift to Continuous Biomanufacturing

BioPharm

SMB technology in the downstream can facilitate the shift to continuous bioprocessing.

52
article thumbnail

Zauberkugel: Pfizer’s Seagen Acquisition

BioPharm

What can we take away from Pfizer's acquisition of Seagen?

52
article thumbnail

Introducing the BIOne 10L Single-Use Bioreactor

BioPharm

The BIOne 10L SUB is highly innovative with expanded processing capabilities, ideal for scale-down modeling, material generation, and process optimization.

52